9. Mitral and tricuspid valve percutaneous replacement
Mitral and tricuspid valve percutaneous replacement surgery is performing heart surgery through a catheter in the skin in a less invasive manner.
“Replace and repair have both seen improvement in the last year,” said Dr. Samir Kapadia, a heart doctor in the Heart and Vascular Institute at the Cleveland Clinic, at this year’s Cleveland Clinic Innovation Summit. Mitral and tricuspid valve percutaneous replacement procedures not only saves lives, but also makes patients feel better with less re-hospitalizations. This is the crucial part where abilities can be improved with expanded indications.
The first procedure was performed in 2016 and involved a replacement valve stent that was replaced through a catheter.
There are a few medical device companies currently in the race to commercialize the first transcatheter mitral valve replacement. Abbott is the only company that has commercialized a TMVR device: the company’s MitraClip.